Cognision partners with Kynexis for use of COGNISION system in schizophrenia trial

CHMP issues positive opinion for DAWNZERA in hereditary angioedema

Merck to acquire Cidara Therapeutics in USD9.2bn deal to expand antiviral portfolio

Eisai and BioArctic's Leqembi gains UK regulatory approval for IV maintenance treatment of Alzheimer's disease

IVI RMA Global Expands Footprint with Acquisition of ART Fertility Clinics, Establishing Middle East as Fifth Operating Region

EirGenix signs second global exclusive licensing deal with Sandoz

Longeveron secures US patent for stem cell therapy targeting aging-related frailty

Anixa Biosciences secures U.S. Patent strengthening breast cancer vaccine IP into mid 2040s

Alkermes reports positive Phase 2 results for alixorexton in narcolepsy type 2

ExpreS2ion Biotech signs definitive licensing deal with Serum Institute of India for novel malaria vaccines

ABIONYX Pharma advances strategic alliance talks with IHU SEPSIS to build global sepsis innovation platform

Shilpa Medicare completes fourth complex clinical program with positive topline Phase three results for Shilpa's OERIS

iLeukon Therapeutics reveals new clinical results for ILKN421H ongoing first-in-human Phase I trial (NCT05978102)

WesternU Collaborates with Kern Medical, CSUB and Bakersfield College to Train Future Doctors in Kern County

Mabwell receives NMPA approval to begin Phase II trial for IL-11-targeting drug for pathological scarring